Nimotuzumab: all 127 studies that test it

Page 2 of 2. Open to participants first (42), then studies with results posted, then the rest; newest registration first within each.

• Nimotuzumab in Combination With TPF(Cisplatin ,Fluorouracil and Docetaxel) for Head and Neck Squamous Cell CarcinomaCompletedNCT01425736Phase 2
• Chemoradiation With or Without Nimotuzumab in Treating Esophageal Cancer Patients Who Suffer With Recurrence in Regional Lymph Nodes After EsophagectomyStatus unknownNCT01402180Phase 2/3
• Safety and Efficacy Study of Target Therapy Combined With Radiotherapy to Treat Senile Locally Advanced SCCHNStatus unknownNCT01393184Phase 2
• Nimotuzumab in Combination With Paclitaxel Liposome and Carboplatin (TP Regimen) for the Advanced NSCLC PatientsStatus unknownNCT01393080Not applicable
• Nimotuzumab With Radiotherapy in the Treatment of Anal Canal CancersTerminatedNCT01382745Phase 2
• Study Comparing Radiation Therapy and Chemotherapy With or Without NimotuzumabWithdrawnNCT01345084Phase 3
• Nimotuzumab Plus Paclitaxel and Cisplatin as 1st Line Treatment for Esophageal Squamous Cell CancerStatus unknownNCT01336049Phase 2
• Study of Nimotuzumab, Radiation Therapy and Cisplatin Versus Radiation Therapy and Cisplatin for Treatment of Stage IB e IVA UCC(CORUS)WithdrawnNCT01301612Phase 2
• A Study of Chemoradiation Associated with Nimotuzumab As the Treatment of Locally Advanced Esophageal CancerCompletedNCT01249352Phase 2/3
• Nimotuzumab in Combination With Chemoradiation for Local Advanced Esophageal Squamous Cell CarcinomaStatus unknownNCT01232374Phase 2
• Combination of Nimotuzumab,Capecitabine and Radiotherapy for Inoperable or Recurrent Gastric CancerStatus unknownNCT01180166Phase 2
• Nimotuzumab and Radiotherapy in Pediatric Patients With GliomaCompletedNCT01145170Phase 2
• Nimotuzumab in Combination With Chemoradiation for Nasopharyngeal CancerStatus unknownNCT01074021Phase 3
• Nimotuzumab in Combination With Cisplatin and Docetaxel for Patients With Advanced Non-small Cell Lung CancerWithdrawnNCT00985998Phase 1
• Nimotuzumab Plus Docetaxel in Chemotherapy-Refractory/Resistant Patients With Advanced Non-Small-Cell Lung CancerTerminatedNCT00983047Phase 2
• Study of Nimotuzumab to Treat Colorectal CancerStatus unknownNCT00972465Phase 2
• Study of Post-Op Adjuvant Concurrent Chemo-RT With or Without Nimotuzumab for Head & Neck CancerActive, not recruitingNCT00957086Phase 3
• Nimotuzumab in Combination With Chemoradiation for Esophageal CancerCompletedNCT00950417Phase 1
• Induction Chemotherapy With Nimotuzumab in Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)CompletedNCT00910117Phase 2
• A Study of Nimotuzumab in Combination With Radiation Therapy in Patients With Brain MetastasesTerminatedNCT00872482Phase 2
• Nimotuzumab in Adults With Glioblastoma MultiformaCompletedNCT00753246Phase 3
• Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell CancerCompletedNCT00702481Phase 2
• Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine GliomaCompletedNCT00600054Phase 2
• Nimotuzumab in Adults With Pancreatic CancerCompletedNCT00561990Phase 2/3
• Study of Nimotuzumab and Irinotecan in Metastatic Colorectal CancerTerminatedNCT00493857Phase 2
• A Study of Nimotuzumab in Combination With External Radiotherapy in Non-Small Cell Lung CancerTerminatedNCT00369447Phase 1/2
• Phase I Study of Nimotuzumab in Solid TumoursCompletedNCT00369252Phase 1

← Nimotuzumab overview